BACKGROUND
Glioblastoma is the deadliest brain cancer, characterized by large cellular diversity. Both neurodevelopment-like and mesenchymal-like cell states have been described, with the latter being strongly implicated in malignancy and disease progression. However, the spatial organization of these mesenchymal-like cell states has not been systematically described outside the tumor bulk.
METHODS
We performed deep single-cell RNA sequencing of rare glioblastoma cases where tissue could be sampled from tumor core to macroscopically normal cortex and 888-plex enhanced electric single-molecule fluorescence in situ hybridization (EEL-FISH) spatial transcriptomics on a large cohort of standard resections. We also established four glioblastoma organoid lines to test in vitro inducibility of mesenchymal-like cell states under hypoxia and blood plasma exposure.
FINDINGS
We discovered that previously defined mesenchymal-like tumor cell states were shared across both malignant and non-malignant cell types and spatially confined to the tumor bulk. Peripheral regions were instead dominated by neurodevelopment-like tumor states and endogenous microglia. In patient-derived organoids and non-malignant astrocytes, the mesenchymal transcriptional state could be reversibly induced in vitro by hypoxia and human plasma, indicative of a wound response. Multiplex single-molecule spatial transcriptomics revealed that the activation of mesenchymal-like states was associated with hypoxia and organized by distance to perivascular niches.
CONCLUSIONS
Our findings clarify the cellular landscape and biology of glioblastoma, wherein the mesenchymal state arises at least partly as a reactive tissue state shared by all cells in the tumor bulk.
FUNDING
This work was supported by Region Stockholm, Erling-Persson Family Foundation (Atlas of Childhood Disease), Hjärnfonden (FO2023-0309), Swedish Research Council (2022-01248), and Torsten Söderberg Foundation.
Alejandro Mossi Albiach, Jokubas Janusauskas, Jesper Kjaer Jacobsen et al.· i Medicina· 0 citations
Quercetin (Quer), a naturally occurring flavonoid, has received significant attention because of its antitumor effectiveness and ability to synergistically enhance chemotherapy-induced effects by counteracting drug resistance. Ovarian cancer (OC) is a highly aggressive malignancy characterized by frequent chemoresistance, yielding treatment failure and recurrence, whereas effective strategies are lacking. This study elucidated the mechanisms underlying the anti-OC effects of Quer. Network pharmacology analysis revealed that the overlapping targets of Quer and OC are associated with oxidative stress. In vitro experiments indicated that Quer inhibited OC cell proliferation and induced canonical ferroptotic features, including shrunken mitochondria, labile Fe2+ overloading, increased lipid peroxidation, mitochondrial membrane potential loss, GSH depletion, and increased MDA levels. Ferrostatin-1 reversed Quer-induced cytotoxicity and ferroptotic phenotypes. Transcriptomic analysis and expression validation revealed NRF2/HO-1/GPX4 axis suppression. Molecular docking captured the stable binding of Quer to NRF2, HO-1, GPX4, and FTH1. NRF2 overexpression partially restored downstream antioxidant defenses but was insufficient to counteract Quer effects, indicating pathway dependence. In vivo, Quer reduced tumor growth and increased cisplatin (DDP) effectiveness without overt hepatorenal histopathology. This study is the first to reveal that Quer induces ferroptosis in OC cells at least partially through NRF2/HO-1/GPX4 antioxidant axis suppression and cisplatin effectiveness enhancement. These findings support further evaluation of Quer as a ferroptosis-priming adjunct to platinum-based OC therapy.
Hui Li, Zhaoxuan Liu, Hailong Shi et al.· Biochemical Pharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.